Distribution and accumulation of 10 nm silver nanoparticles in maternal tissues and visceral yolk sac of pregnant mice, and a potential effect on embryo growth

被引:54
作者
Austin, Carlye A. [1 ]
Hinkley, Georgia K. [2 ]
Mishra, Anurag R. [3 ]
Zhang, Qin [3 ]
Umbreit, Thomas H. [3 ]
Betz, Martha W. [3 ]
Wildt, Bridget E. [3 ]
Casey, Brendan J. [3 ]
Francke-Carroll, Sabine [4 ]
Hussain, Saber M. [5 ]
Roberts, Stephen M. [2 ]
Brown, Ken M. [1 ]
Goering, Peter L. [3 ]
机构
[1] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA
[2] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA
[3] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA
[4] US FDA, Ctr Food Safety & Nutr, College Pk, MD USA
[5] Air Force Res Lab, Dayton, OH USA
关键词
Development; fetus; nanoparticles; nanosilver; pregnancy; toxicity; ORAL-EXPOSURE; PLACENTA; TOXICITY; TRANSFERRIN; TRANSPORT; STORAGE; IONS; RATS;
D O I
10.3109/17435390.2015.1107143
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
We examined the distribution of silver in pregnant mice and embryos/fetuses following intravenous injections of 10 nm silver nanoparticles (AgNPs) or soluble silver nitrate (AgNO3) at dose levels of 0 (citrate buffer control) or 66 mg Ag/mouse to pregnant mice on gestation days (GDs) 7, 8 and 9. Selected maternal tissues and all embryos/fetuses from control, AgNP- and AgNO3-treated groups on GD10 and control and AgNP-treated groups on GD16 were processed for the measurement of silver concentrations, intracellular AgNP localization, histopathology and gross examination of tissue morphology. Inductively-coupled plasma mass spectrometry revealed silver in all examined tissues following either AgNP or AgNO3 treatment, with highest concentrations of silver in maternal liver, spleen and visceral yolk sac (VYS), and lowest concentrations in embryos/fetuses. For VYS, mean silver concentration following AgNO3 treatment (4.87 ng Ag/mg tissue) was approximately two-fold that following AgNP treatment (2.31 ng Ag/mg tissue); for all other tissues examined, mean silver concentrations following either AgNP or AgNO3 treatment were not significantly different from each other (e.g. 2.57 or 2.84 ng Ag/mg tissue in maternal liver and 1.61 or 2.50 ng Ag/mg tissue in maternal spleen following AgNP or AgNO3 treatment, respectively). Hyperspectral imaging revealed AgNP aggregates in maternal liver, kidney, spleen and VYS from AgNP-treated mice, but not AgNO3-treated mice. Additionally, one or more embryos collected on GD10 from eight of ten AgNP-treated mice appeared small for their age (i.e. Theiler stage 13 [GD8.5] or younger). In the control group (N = 11), this effect was seen in embryos from only one mouse. In conclusion, intravenous injection of 10 nm AgNPs to pregnant mice resulted in notable silver accumulation in maternal liver, spleen and VYS, and may have affected embryonic growth. Silver accumulation in embryos/fetuses was negligible.
引用
收藏
页码:654 / 661
页数:8
相关论文
共 31 条
  • [1] [Anonymous], 2014, CONPROD INV
  • [2] Distribution of silver nanoparticles in pregnant mice and developing embryos
    Austin, Carlye A.
    Umbreit, Thomas H.
    Brown, Ken M.
    Barber, David S.
    Dair, Benita J.
    Francke-Carroll, Sabine
    Feswick, April
    Saint-Louis, Melissa A.
    Hikawa, Hiroyuki
    Siebein, Kerry N.
    Goering, Peter L.
    [J]. NANOTOXICOLOGY, 2012, 6 (08) : 912 - 922
  • [3] Cadmium Associated With Inhaled Cadmium Oxide Nanoparticles Impacts Fetal and Neonatal Development and Growth
    Blum, Jason L.
    Xiong, Judy Q.
    Hoffman, Carol
    Zelikoff, Judith T.
    [J]. TOXICOLOGICAL SCIENCES, 2012, 126 (02) : 478 - 486
  • [4] UPTAKE AND STORAGE OF THOROTRAST BY RODENT YOLK SAC PLACENTA - AN ELECTRON MICROSCOPIC STUDY
    CARPENTER, SJ
    FERM, VH
    [J]. AMERICAN JOURNAL OF ANATOMY, 1969, 125 (04): : 429 - +
  • [5] The Mammalian Yolk Sac Placenta
    Freyer, Claudia
    Renfree, Marilyn B.
    [J]. JOURNAL OF EXPERIMENTAL ZOOLOGY PART B-MOLECULAR AND DEVELOPMENTAL EVOLUTION, 2009, 312B (06) : 545 - 554
  • [6] Groman EV, 2004, CONTEMP TOP LAB ANIM, V43, P35
  • [7] Oral absorption of PEG-coated versus uncoated gold nanospheres: does agglomeration matter?
    Hinkley, Georgia K.
    Carpinone, Paul
    Munson, John W.
    Powers, Kevin W.
    Roberts, Stephen M.
    [J]. PARTICLE AND FIBRE TOXICOLOGY, 2015, 12
  • [8] Combined repeated-dose toxicity study of silver nanoparticles with the reproduction/developmental toxicity screening test
    Hong, Jeong-Sup
    Kim, Suhyon
    Lee, Sang Hee
    Jo, Eunhye
    Lee, Byungcheun
    Yoon, Junheon
    Eom, Ig-Chun
    Kim, Hyun-Mi
    Kim, Pilje
    Choi, Kyunghee
    Lee, Moo Yeol
    Seo, Yeong-Rok
    Kim, Younghun
    Lee, Yeonjin
    Choi, Jonghye
    Park, Kwangsik
    [J]. NANOTOXICOLOGY, 2014, 8 (04) : 349 - 362
  • [9] Antimicrobial activities of silver dressings:: an in vitro comparison
    Ip, M
    Lui, SL
    Poon, VKM
    Lung, I
    Burd, A
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (01) : 59 - 63
  • [10] Rapid determination of plasmonic nanoparticle agglomeration status in blood
    Jenkins, Samir V.
    Qu, Haiou
    Mudalige, Thilak
    Ingle, Taylor M.
    Wang, Rongrong
    Wang, Feng
    Howard, Paul C.
    Chen, Jingyi
    Zhang, Yongbin
    [J]. BIOMATERIALS, 2015, 51 : 226 - 237